Wariness about taking AstraZeneca’s Covid-19 vaccine in Africa could be compounded by the African Union’s decision to halt plans to procure the shot, health experts said, calling for public awareness programmes to fight misinformation.
The African Union (AU) said its announcement was not related to recent findings by European and British medicine regulators that there are possible links between the vaccine and extremely rare blood clots, but rather a case of diversifying options.
Still, experts said the timing of the announcement could fuel vaccine hesitancy.
Read full Reuters story here.
